Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.83−0.24 (-2.97%)
Close on Nov 19, 2026Market cap $451.68MP/E –Yield –
Kamada gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Kamada's gross profit for the twelve months ending Jun 30, 2026 was $78.31M, up 5.9% year over year. For fiscal 2025 it was $76.41M, up 9.2% from the year before. Over ten years it grew 17.4% a year on average. The highest annual figure on record is $76.41M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.41M | +9.2% |
| FY2024 | Dec 31, 2024 | $69.97M | +26.1% |
| FY2023 | Dec 31, 2023 | $55.49M | +18.8% |
| FY2022 | Dec 31, 2022 | $46.70M | +54.0% |
| FY2021 | Dec 31, 2021 | $30.33M | -36.2% |
| FY2020 | Dec 31, 2020 | $47.55M | -4.4% |
| FY2019 | Dec 31, 2019 | $49.74M | +19.9% |
| FY2018 | Dec 31, 2018 | $41.47M | +29.2% |
| FY2017 | Dec 31, 2017 | $32.09M | +50.2% |
| FY2016 | Dec 31, 2016 | $21.36M | +39.0% |
| FY2015 | Dec 31, 2015 | $15.37M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.47M | +18.7% |
| Q1 FY2026 | Mar 31, 2026 | $19.12M | -7.9% |
| Q4 FY2025 | Dec 31, 2025 | $16.97M | -0.4% |
| Q3 FY2025 | Sep 30, 2025 | $19.76M | +14.7% |
| Q2 FY2025 | Jun 30, 2025 | $18.93M | -0.1% |
| Q1 FY2025 | Mar 31, 2025 | $20.75M | +23.9% |
| Q4 FY2024 | Dec 31, 2024 | $17.03M | +18.2% |
| Q3 FY2024 | Sep 30, 2024 | $17.23M | +16.4% |
| Q2 FY2024 | Jun 30, 2024 | $18.95M | +31.3% |
| Q1 FY2024 | Mar 31, 2024 | $16.75M | +141390.0% |
| Q4 FY2023 | Dec 31, 2023 | $14.41M | -69.1% |
| Q3 FY2023 | Sep 30, 2023 | $14.80M | +114919.4% |
| Q2 FY2023 | Jun 30, 2023 | $14.44M | +99.4% |
| Q1 FY2023 | Mar 31, 2023 | $11.84K | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $46.67M | +607.7% |
| Q3 FY2022 | Sep 30, 2022 | $12.87K | -99.8% |
| Q2 FY2022 | Jun 30, 2022 | $7.24M | -20.2% |
| Q1 FY2022 | Mar 31, 2022 | $11.30M | +11.2% |
| Q4 FY2021 | Dec 31, 2021 | $6.60M | -55.5% |
| Q3 FY2021 | Sep 30, 2021 | $5.73M | – |
| Q2 FY2021 | Jun 30, 2021 | $9.07M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.17M | – |
| Q3 FY2020 | Sep 30, 2020 | $14.82M | – |
See a number that looks wrong?